image
Financial Services - Financial - Capital Markets - NYSE - JP
$ 6.51
1.09 %
$ 19.2 B
Market Cap
9.17
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one NMR stock under the worst case scenario is HIDDEN Compared to the current market price of 6.51 USD, Nomura Holdings, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one NMR stock under the base case scenario is HIDDEN Compared to the current market price of 6.51 USD, Nomura Holdings, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one NMR stock under the best case scenario is HIDDEN Compared to the current market price of 6.51 USD, Nomura Holdings, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
1.56 REVENUE
35.76%
796 B OPERATING INCOME
-38.89%
177 B NET INCOME
93.31%
133 B OPERATING CASH FLOW
113.61%
-888 B INVESTING CASH FLOW
-2279.98%
1.01 FINANCING CASH FLOW
-21.59%
458 B REVENUE
4.64%
(1.67) OPERATING INCOME
0.00%
68.9 B NET INCOME
21.48%
0 OPERATING CASH FLOW
0.00%
0 INVESTING CASH FLOW
100.00%
0 FINANCING CASH FLOW
0.00%
Balance Sheet Nomura Holdings, Inc.
image
Current Assets 4.24
Cash & Short-Term Investments 4.24
Receivables 1.68
Other Current Assets (1.68)
Non-Current Assets 50.9
Long-Term Investments 14
PP&E 449 B
Other Non-Current Assets 36.5
Current Liabilities 0
Accounts Payable 1.31
Short-Term Debt 1.05
Other Current Liabilities (2.37)
Non-Current Liabilities 51.7
Long-Term Debt 13
Other Non-Current Liabilities 38.7
EFFICIENCY
Earnings Waterfall Nomura Holdings, Inc.
image
Revenue 1.56
Cost Of Revenue 2.79
Gross Profit (1.23)
Operating Expenses 766 B
Operating Income 796 B
Other Expenses 618 B
Net Income 177 B
RATIOS
-102.75% GROSS MARGIN
-102.75%
19.85% OPERATING MARGIN
19.85%
12.04% NET MARGIN
12.04%
4.95% ROE
4.95%
0.30% ROA
0.30%
0.25% ROIC
0.25%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Nomura Holdings, Inc.
image
Net Income 177 B
Depreciation & Amortization 61.3 B
Capital Expenditures -146 B
Stock-Based Compensation 51.5 B
Change in Working Capital -116 B
Others -867 B
Free Cash Flow -13.1 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Nomura Holdings, Inc.
image
Wall Street analysts predict an average 1-year price target for NMR of $5.79 , with forecasts ranging from a low of $5.79 to a high of $5.79 .
NMR Lowest Price Target Wall Street Target
5.79 USD -11.06%
NMR Average Price Target Wall Street Target
5.79 USD -11.06%
NMR Highest Price Target Wall Street Target
5.79 USD -11.06%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.13 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Nomura Holdings, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 years ago
Jan 30, 2023
Sell 9.18 K USD
NOMURA SECURITIES INTERNATIONAL INC
- 7986
1.15 USD
7. News
NMR vs. BAC: Which Stock Is the Better Value Option? Investors with an interest in Financial - Investment Bank stocks have likely encountered both Nomura Holdings (NMR) and Bank of America (BAC). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 2 weeks ago
Should Value Investors Buy Nomura (NMR) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 weeks ago
Nomura Holdings, Inc. (NMR) Q3 2025 Earnings Conference Call Transcript Nomura Holdings, Inc. (NYSE:NMR ) Q3 2025 Earnings Conference Call February 5, 2025 3:00 AM ET Company Participants Takumi Kitamura - Chief Financial Officer Conference Call Participants Masao Muraki - SMBC Nikko Securities Natsumu Tsujino - BofA Securities Kazuki Watanabe - Daiwa Securities Koichi Niwa - Citigroup Securities Natsumu Tsujino - Bank of America Operator Good day, everyone, and welcome to today's Nomura Holdings third quarter operating results for fiscal year ending March 2025 conference call. Please be reminded that today's conference call is being recorded at the request of the hosting company. seekingalpha.com - 3 weeks ago
Nomura Holdings (NMR) Is Up 3.51% in One Week: What You Should Know Does Nomura Holdings (NMR) have what it takes to be a top stock pick for momentum investors? Let's find out. zacks.com - 3 weeks ago
NMR vs. BAC: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Financial - Investment Bank sector have probably already heard of Nomura Holdings (NMR) and Bank of America (BAC). But which of these two stocks is more attractive to value investors? zacks.com - 1 month ago
Should Value Investors Buy Nomura (NMR) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 month ago
MoneyShow's Best Investment Ideas For 2025: Part 2 MoneyShow presents top investment ideas for 2025 from their contributors. This year's edition presents a broad mix of theme-based stock picks, momentum-driven high-flyers and beaten-up stocks with turnaround potential, along with some speculative plays and ETFs. Part 2 of this series includes Neo Performance Metals, Fannie Mae, Agnico Eagle, AbbVie, Morgan Stanley and Nomura Holdings, among others. seekingalpha.com - 1 month ago
4 Lucrative PEG Stocks Based on GARP Investment Strategy PEG-based GARP stocks that fit our screening criteria are FUJHY, ENS, NMR and AAL. zacks.com - 1 month ago
Nomura (NMR) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Nomura (NMR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. zacks.com - 1 month ago
Should Value Investors Buy Nomura (NMR) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 month ago
Are Investors Undervaluing Nomura (NMR) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 months ago
Nanalysis and The United States Pharmacopeia (USP) Co-Publish Study Demonstrating Efficacy of Benchtop NMR for Quality Control CALGARY, AB , Dec. 11, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and research applications announces results of study by the United States Pharmacopeia (USP) concluding that benchtop NMR is efficacious for quality control of active pharmaceutical ingredients (API). "In the not-too-distant future, we expect that benchtop NMR will become an important tool in the multi-billion-dollar market for quality control in the pharmaceutical industry," said Sean Krakiwsky, Founder and CEO of Nanalysis. prnewswire.com - 2 months ago
8. Profile Summary

Nomura Holdings, Inc. NMR

image
COUNTRY JP
INDUSTRY Financial - Capital Markets
MARKET CAP $ 19.2 B
Dividend Yield 0.00%
Description Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Retail, Investment Management, and Wholesale. The Retail segment offers various financial products and investment services. As of March 31, 2022, this segment operated a network of 119 branches. The Investment Management segment engages in the management of funds, investment trusts, and other investment vehicles; and provision of investment advisory, custodial, and administrative services. The Wholesale segment is involved in the research, sale, trading, agency execution, and market-making of fixed income and equity-related products. It also engages in underwriting various securities and other financial instruments, such as various classes of shares, convertible and exchangeable securities, investment grade and high yield debts, sovereign and emerging market debts, structured securities, and other securities; arranging private placements, as well as other capital raising activities; and the provision of financial advisory services on business transactions comprising mergers and acquisitions, divestitures, spin-offs, capital structuring, corporate defense activities, leveraged buyouts, and risk solutions. In addition, this segment offers various financial instruments. The company was formerly known as The Nomura Securities Co., Ltd. and changed its name to Nomura Holdings, Inc. in October 2001. Nomura Holdings, Inc. was incorporated in 1925 and is headquartered in Tokyo, Japan.
Contact 13-1, Nihonbashi 1-chome, Tokyo, 103-8645 https://www.nomuraholdings.com
IPO Date Dec. 17, 2001
Employees 26850
Officers Yosuke Inaida Executive Officer of Global Regulatory Affairs Mr. Christopher Paul Willcox Executive Officer & Head of Wholesale Mr. Takumi Kitamura Chief Financial Officer, Executive Officer & Chief Transformation Officer Mr. Gareth Nicholson Executive Director, Chief Investment Officer & Head of Discretionary Portfolio Management Ms. Junko Tago Executive Director, Head of Investor Relations Mr. Toshiyasu Iiyama Chief of Staff, Executive Officer & Deputy President Mr. Yutaka Nakajima Representative Executive Officer and Deputy President & Head of Global Markets and Director Mr. Masahiro Goto Senior MD & Global Head of Investment Banking Mr. Patrick Eltridge Senior MD & Chief Information Officer Mr. Kentaro Okuda President, Group Chief Executive Officer, Representative Executive Officer & Director